Novel Druggable Targets in Neuroinflammation and Neuroimmunity
Vanderbilt University
Servier is seeking novel therapeutic proposals targeting neuroinflammation/neuroimmunity for CNS/PNS diseases.
Reference No.
RFP-2025-3128
Category
Research/Development
Due Date
December 1st, 2025
Description
Servier, a leading international pharmaceutical company, seeks novel therapeutic proposals targeting neuroinflammation and/or neuroimmunity in central nervous system and/or peripheral nervous system diseases
Key Requirements
RFP Submission Requirements for Vanderbilt Neuroinflammation Targets
Contact Information
What you’ll get when you unlock
All the details after a short form. No spam
- Latest RFP PDF
- Buyer contact sheet
- Submission checklist
- Any addenda links